|
1.
|
Department of Health, Executive Yuan,
Taipei, Taiwan R.O.C: Statistics of Causes of Death, 2007. p33,
2008.
|
|
2.
|
A JemalRC TiwariT MurrayCancer statistics,
2004CA Cancer J Clin54829200410.3322/canjclin.54.1.8
|
|
3.
|
SC WeiYN SuJJ Tsai-WuGenetic analysis of
the APC gene in Taiwanese familial adenomatous polyposisJ Biomed
Sci11260265200410.1007/BF0225656914966376
|
|
4.
|
MJ VerhoefLG BalneavesHS BoonA
VroegindeweyReasons for and characteristics associated with
complementary and alternative medicine use among adult cancer
patients: a systematic reviewIntegr Cancer
Ther4274286200510.1177/153473540528236116282504
|
|
5.
|
H BoonJ WongBotanical medicine and cancer:
a review of the safety and efficacyExpert Opin
Pharmacother524852501200410.1517/14656566.5.12.248515571467
|
|
6.
|
JM FishDR WelchonsYS KimSH LeeWK HoC
AntzelevitchDimethyl lithospermate B, an extract of Danshen,
suppresses arrhythmogenesis associated with the Brugada
syndromeCirculation11313931400200610.1161/CIRCULATIONAHA.105.60169016534004
|
|
7.
|
PN ChangJC MaoSH HuangAnalysis of
cardio-protective effects using purified Salvia miltiorrhiza
extract on isolated rat heartsJ Pharmacol
Sci101245249200610.1254/jphs.FPJ05034X
|
|
8.
|
AJ CheJY ZhangCH LiXF ChenZD HuXG
ChenSeparation and determination of active components in Radix
Salviae miltiorrhizae and its medicinal preparations by
nonaqueous capillary electrophoresisJ Sep
Sci27569575200415335042
|
|
9.
|
L ZhouZ ZuoMS ChowDanshen: an overview of
its chemistry, pharmacology, pharmacokinetics, and clinical useJ
Clin Pharmacol4513451359200510.1177/009127000528263016291709
|
|
10.
|
SI JangHJ KimYJ KimSI JeongYO
YouTanshinone IIA inhibits LPS induced NF-kappaB activation in RAW
264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and
JNK pathwaysEur J
Pharmacology54217200610.1016/j.ejphar.2006.04.04416797002
|
|
11.
|
W LiJ LiM AshokR WuA cardiovascular drug
rescues mice from lethal sepsis by selectively attenuating a
late-acting pro-inflammatory mediator, high mobility group box 1J
Immunology7838563864200710.4049/jimmunol.178.6.385617339485
|
|
12.
|
R LinWR WangJT LiuGD YangCJ HanProtective
effect of Tanshinone IIA on human umbilical vein endothelial cell
injured by hydrogen peroxide and its mechanismJ
Ethnopharmacol108217222200610.1016/j.jep.2006.05.00416797899
|
|
13.
|
AM WangSH ShaW LesniakJ SchachtTanshinone
(Salviae miltiorrhizae extract) preparations attenuate
aminoglycoside-induced free radical formation in vitro and
ototoxicity in vivoAntimicrob Agents Chemother47183618412003
|
|
14.
|
CC SuGW ChenJC KangMH ChanGrowth
inhibition and apoptosis induction by tanshinone IIA in human colon
adenocarcinoma cellsPlanta
Med7413571362200810.1055/s-2008-108129918622903
|
|
15.
|
CC SuYH LinTanshinone IIA inhibits human
breast cancer cells through increased Bax to Bcl-xL ratiosInt J Mol
Med22357361200818698495
|
|
16.
|
I ChauAR NormanD CunninghamA randomised
comparison between 6 months of bolus fluorouracil/leucovorin and 12
weeks of protracted venous infusion fluorouracil as adjuvant
treatment in colorectal cancerAnn
Oncol16549557200510.1093/annonc/mdi116
|
|
17.
|
HC ChenWT HsiehWC ChangJG ChungAloe-emodin
induced in vitro G2/M arrest of cell cycle in human promyelocytic
leukemia HL-60 cellsFood Chem
Toxicol4212511257200410.1016/j.fct.2004.03.00215207375
|
|
18.
|
MM BradfordA rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye bindingAnal
Biochem72248254197610.1016/0003-2697(76)90527-3942051
|
|
19.
|
MM GottesmanI PastanSV
AmbudkarP-glycoprotein and multidrug resistanceCurr Opin Genet
Dev6610617199610.1016/S0959-437X(96)80091-88939727
|
|
20.
|
BL LumMP GoslandS KaubischBI
SikicMolecular targets in oncology: implications of the multidrug
resistance genePharmacotherapy138810919938097038
|
|
21.
|
J LiN HouA FariedS TsutsumiT TakeuchiH
KuwanoInhibition of autophagy by 3-MA enhances the effect of
5-FU-induced apoptosis in colon cancer cellsAnn Surg
Oncol16761771200910.1245/s10434-008-0260-019116755
|
|
22.
|
P AlbertssonB LennernäsK NorrbyLow-dose
continuous 5-fluorouracil infusion stimulates VEGF-A-mediated
angiogenesisActa
Oncol48418425200910.1080/0284186080240951218932044
|
|
23.
|
K KirkegaardMP TaylorWT JacksonCellular
autophagy: Surrender, avoidance and subversion by microorganismsNat
Rev Microbiol2301314200410.1038/nrmicro86515031729
|
|
24.
|
EL EskelinenAR PrescottJ CooperInhibition
of autophagy in mitotic animal
cellsTraffic3878893200210.1034/j.1600-0854.2002.31204.x12453151
|
|
25.
|
YJ FangZH LuGQ WangZZ PanZW ZhouJP YunMF
ZhangDS WanElevated expressions of MMP7, TROP2, and survivin are
associated with survival, disease recurrence, and liver metastasis
of colon cancerInt J Colorectal
Dis24875884200910.1007/s00384-009-0725-z19421758
|
|
26.
|
WL XuJR LiuHK LiuGY QiXR SunWG SunBQ
ChenInhibition of proliferation and induction of apoptosis by
gamma-tocotrienol in human colon carcinoma HT-29
cellsNutrition25555566200910.1016/j.nut.2008.10.01919121919
|
|
27.
|
D HeQ XuM YanP ZhangX ZhouZ ZhangW DuanL
ZhongD YeW ChenThe NF-kappa B inhibitor, celastrol, could enhance
the anti-cancer effect of gambogic acid on oral squamous cell
carcinomaBMC Cancer9343200910.1186/1471-2407-9-34319778460
|
|
28.
|
R VoborilSN HochwJ LiA BrankJ WeberovaF
WesselsLL MoldawerER CampSL MacKayInhibition of NF-kappa B augments
sensitivity to 5-fluorouracil/folinic acid in colon cancerJ Surg
Res120178188200410.1016/j.jss.2003.11.02315234211
|
